Brace Pharma Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 4

Professionals
  • Investments
  • 27

  • Portfolio
  • 10

  • Exits
  • 9

Exits

Brace Pharma Capital General Information

Description

Founded in 2013, Brace Pharma Capital is a corporate venture capital firm that is based in Atlanta, Georgia. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm prefers to invest in the healthcare, life sciences, and oncology sectors.

Contact Information

Year Founded
2013
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 55 Ivan Alan Junior Boulevard
  • Suite 525
  • Atlanta, GA 30308
  • United States
+1 (240) 000-0000

Brace Pharma Capital Investments (27)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Antiva Biosciences 02-Nov-2021 Later Stage VC 0000 Drug Discovery Generating Revenue 0000000 0000000
000000000 00000000 14-Jul-2021 00000 00000 0000 Drug Discovery Generating Revenue
00000000 000000000 11-Feb-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000 00000
0000000 25-Aug-2020 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2
000 12-Aug-2020 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2
0000000 0000000000 21-May-2020 00000 00000 0000 Drug Discovery Generating Revenue
00000000 000000000 18-Dec-2019 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000 00000
0000000 0000000000 13-Nov-2019 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable 0000 00000
Precision BioSciences 01-Mar-2019 Later Stage VC 00000 Biotechnology Generating Revenue/Not Profitable
Turnstone Biologics 04-Jan-2019 Later Stage VC 0000 Drug Discovery Generating Revenue
You’re viewing 10 of 27 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Brace Pharma Capital Exits (9)

Company Name Exit Date Exit Type Exit Size
Avidity Biosciences 12-Jun-2020 IPO 00000
000000000 00000000 28-Mar-2019 000 00000
000000000 00000000 01-Nov-2018 000 00 00000000
0000000 21-Jun-2018 000 00000
000000 00000000000 29-Mar-2018 000 000.00
000000000 28-Apr-2017 000 000.00
Cocrystal Pharma 02-Jan-2014 Reverse Merger
Viridian Therapeutics Secondary Transaction - Open Market
You’re viewing 8 of 9 exits. Get the full list »

Brace Pharma Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Brace Pharma Capital Team (15)

Name Title Deals Funds Boards Office
Vinzenz Ploerer President & Chief Executive Officer 0 0 0 Rockville, MD
Jorge Costa Ph.D Co-Founding Director & Member of Scientific Advisory Board Cambridge, MA
Todd Brady Director of Finance & Investments 0 0 0 Rockville, MD
Racheal Smith Executive Assistant & Office Manager Atlanta, GA
Daniel Salazar Ph.D Vice President of Clinical & Regulatory 0 Rockville, MD
You’re viewing 5 of 15 team members. Get the full list »

Brace Pharma Capital Co-Investors (89)

Name With Exits Lead Partner Series Industry
Alexandria Venture Investments 3 0 Series chart Industry bar
Cormorant Asset Management 0 0 0 Series chart Industry bar
Perceptive Advisors 0 0 0 Series chart Industry bar
Atlas Venture 0 0 0 Series chart Industry bar
Franklin Templeton 0 0 Series chart Industry bar
You’re viewing 5 of 89 co-investors. Get the full list »